FAA launches MedGuide tool to help pilots check medication safety

The FAA's Office of Aerospace Medicine this month introduced MedGuide, an online tool that can tell pilots and air traffic controllers which medications are considered acceptable for use while performing flight or safety-related duties. According to Flying Magazine, the tool partially addresses a longstanding information gap in aviation medical certification.

Users can search for generic or brand-name drugs and over-the-counter medications using a drop-down menu or by typing them manually. The tool then returns FAA frequency limits—typically as prescribed on the label—and wait times for the medication, depending on the user's role.

For most drugs, MedGuide includes an initial wait time, or observation period required after starting a new medication before returning to safety-related duties. Flying Magazine reports this is typically 48 hours but can be longer or shorter depending on the drug.

Some medications have a different wait time after subsequent doses to mitigate aeromedically significant side effects. They may also have a discontinuation wait time, required to verify that the user's condition is stable and there is no risk of rebound symptoms or withdrawal after stopping a medication.

MedGuide also allows users to select the underlying conditions for which they are being treated, which the FAA says is critical to determining safety of flight and can impact wait times.

Current coverage and planned expansion

Version 1.0 of MedGuide contains only approved medications. According to Flying Magazine, future iterations will add conditional and unacceptable medications, expanding the tool's utility for airmen and air traffic controllers evaluating their fitness to operate.

The FAA states on its website that MedGuide is not a stand-in for medical diagnosis or treatment and "should not be used as the sole basis in making aeromedical determinations, which must include an individualized assessment." It is positioned as a reference for airman medical certification and air traffic control specialist clearance.

Mark Larsen, director of safety and flight operations for the National Business Aviation Association (NBAA), said in a news release that "This tool, while still a work in progress, equips aviators to make safe, fit-for-flight decisions about medication use." Larsen added that "Pilots are accustomed to clear, if-then directions, and MedGuide offers a more direct way to understand both prescription and over-the-counter medications, including any wait time after an initial or subsequent dose."

It remains unclear from available reporting whether MedGuide covers all classes of medications pilots commonly use, or how frequently the FAA plans to update the tool with new drugs and conditional medications.